Your browser doesn't support javascript.
loading
Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients.
Chmielewski, M; Carrero, J J; Qureshi, A R; Axelsson, J; Heimbürger, O; Berglund, L; Bárány, P; Rutkowski, B; Lindholm, B; Stenvinkel, P.
Afiliación
  • Chmielewski M; Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. chmiel@amg.gda.pl
J Intern Med ; 265(6): 708-16, 2009 Jun.
Article en En | MEDLINE | ID: mdl-19298498
BACKGROUND: In the general population, a high apoB/apoA-I ratio is a strong risk factor for cardiovascular disease and mortality. However, whether this is the case in chronic kidney disease (CKD) patients is currently unknown. STUDY DESIGN: The apoB/apoA-I ratio was evaluated in 391 incident CKD stage 5 patients examined close to dialysis initiation, and again after 1 year of dialysis in a subgroup of 182 patients, subsequently followed for up to 3 years. RESULTS: Baseline values of the apoB/apoA-I ratio as well as changes in the ratio during the first year of dialysis correlated with body mass index (BMI) and fat mass. The baseline apoB/apoA-I ratio showed no association with 4-year mortality. However, after adjustment for confounders, a high apoB/apoA-I ratio (>0.9) predicted short-term (first year) survival [hazard ratio (HR): 0.35; 95% confidence interval (CI): 0.13-0.85)] and long-term (next 3 years) mortality (HR: 1.72; 95% CI: 1.01-2.96). An increase in the apoB/apoA-I ratio during the first year of dialysis was linked to a survival advantage thereafter (HR: 0.48; 95% CI: 0.22-0.98). However, this association lost its significance (HR: 0.62; 95% CI: 0.26-1.36) after adjustment for indices of protein-energy wasting. CONCLUSIONS: A high apoB/apoA-I ratio and an increase in this ratio during the first year on dialysis were associated with short-term survival advantage in CKD patients. This paradoxical relationship represents an example of the so-called reverse epidemiology phenomenon in CKD patients and suggests that the apoB/apoA-I ratio should always be interpreted with caution in this patient population.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Apolipoproteínas B / Diálisis Renal / Apolipoproteína A-I / Nefropatías Diabéticas / Fallo Renal Crónico Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2009 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Apolipoproteínas B / Diálisis Renal / Apolipoproteína A-I / Nefropatías Diabéticas / Fallo Renal Crónico Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2009 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido